American Oncology Network... (AONC)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

1.75

-61.58%

After-hours Jun 07, 2024, 07:59 PM EDT

Company Description

American Oncology Network, Inc., through its subsidiaries, provides oncology services in the United States.

The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance.

The company was incorporated in 2017 and is based in Fort Myers, Florida.

American Oncology Network Inc.

Country	United States
IPO Date	May 5, 2021
Industry	Medical - Care Facilities
Sector	Healthcare
Employees	1,525
CEO	Todd Schonherz

Contact Details

Address: 14543 Global Parkway Fort Myers, Florida United States
Website	https://www.aoncology.com

Stock Details

Ticker Symbol	AONC
Exchange	NASDAQ
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001839998
CUSIP Number	028719102
ISIN Number	US0287191029
Employer ID	00-0000000
SIC Code	6770

Key Executives

Name	Position
Todd Schonherz	Chief Executive Officer & Director
David Afshar CPA	Principal Accounting Officer, Chief Financial Officer & Chief Operating Officer
Mark Moch	Chief Information Officer
Caroline Hewitt	Vice President of Marketing
Dr. Stephen Divers M.D.	Chief Medical Officer, VC of Board of Managers & Chairman of Advisory Board Executive Committee
Erica Mallon	General Counsel
James Gilmore Pharm.D.	Chief Pharmacy & Clinical Services Officer
Karen Pilley	Chief Revenue Cycle Officer
Karen Quick	Vice President of Human Resources
Kristin Matisziw	Chief Compliance & Risk Officer

Latest SEC Filings

Date	Type	Title
Dec 12, 2024	S-8 POS	Filing
Dec 12, 2024	POS AM	Filing
Nov 15, 2024	424B3	Filing
Nov 13, 2024	10-Q	Quarterly Report
Aug 15, 2024	424B3	Filing
Aug 14, 2024	10-Q	Quarterly Report
Jul 26, 2024	424B3	Filing
Jul 25, 2024	8-K	Current Report
Jul 18, 2024	4	Filing
Jul 18, 2024	4	Filing

View All SEC Filings